GSA CAPITAL PARTNERS LLP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 72 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$386,000
+21.0%
324,784
+16.2%
0.05%
+18.6%
Q1 2022$319,000
+3.9%
279,605
+211.1%
0.04%
+38.7%
Q3 2021$307,000
-52.8%
89,878
-58.7%
0.03%
-57.5%
Q2 2021$651,000
-15.6%
217,687
-23.4%
0.07%
+69.8%
Q3 2018$771,000
+39.2%
284,354
-1.9%
0.04%
+59.3%
Q2 2018$554,000
-12.8%
289,854
-4.1%
0.03%
-20.6%
Q1 2018$635,000
+2167.9%
302,154
+2112.9%
0.03%
+1600.0%
Q4 2017$28,000
-89.7%
13,654
-29.8%
0.00%
-81.8%
Q1 2015$272,00019,4460.01%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders